Role of glucagon-like peptide-1 agonists in obesity and heart failure with preserved ejection fraction
PL Temporelli - European Heart Journal Supplements, 2024 - academic.oup.com
Heart failure with preserved ejection fraction (HFpEF) currently represents the majority of all
heart failure cases in the community. Glucagon-like peptide-1 agonists represent a class of …
heart failure cases in the community. Glucagon-like peptide-1 agonists represent a class of …
[HTML][HTML] Role of glucagon-like peptide-1 agonists in obesity and heart failure with preserved ejection fraction
PL Temporelli - European Heart Journal Supplements: Journal of …, 2024 - ncbi.nlm.nih.gov
Heart failure with preserved ejection fraction (HFpEF) currently represents the majority of all
heart failure cases in the community. Glucagon-like peptide-1 agonists represent a class of …
heart failure cases in the community. Glucagon-like peptide-1 agonists represent a class of …
Role of glucagon-like peptide-1 agonists in obesity and heart failure with preserved ejection fraction.
PL Temporelli - European Heart Journal Supplements: Journal of …, 2024 - europepmc.org
Heart failure with preserved ejection fraction (HFpEF) currently represents the majority of all
heart failure cases in the community. Glucagon-like peptide-1 agonists represent a class of …
heart failure cases in the community. Glucagon-like peptide-1 agonists represent a class of …
Role of glucagon-like peptide-1 agonists in obesity and heart failure with preserved ejection fraction
PL Temporelli - … heart journal supplements: journal of the …, 2024 - pubmed.ncbi.nlm.nih.gov
Heart failure with preserved ejection fraction (HFpEF) currently represents the majority of all
heart failure cases in the community. Glucagon-like peptide-1 agonists represent a class of …
heart failure cases in the community. Glucagon-like peptide-1 agonists represent a class of …